These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32468823)

  • 1. The Clinical Significance of IGF-1R and Relationship with Epstein-Barr Virus Markers: LMP1 and EBERs in Tunisian Patients with Nasopharyngeal Carcinoma.
    Baizig NM; Wided BA; Amine OE; Gritli S; ElMay M
    Ann Otol Rhinol Laryngol; 2020 Oct; 129(10):1011-1019. PubMed ID: 32468823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.
    Rosales-Pérez S; Cano-Valdez AM; Flores-Balcázar CH; Guedea-Edo F; Lino-Silva LS; Lozano-Borbalas A; Navarro-Martín A; Poitevin-Chacón A
    Arch Med Res; 2014 Apr; 45(3):229-36. PubMed ID: 24606815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.
    Li J; Zhang XS; Xie D; Deng HX; Gao YF; Chen QY; Huang WL; Masucci MG; Zeng YX
    Cancer Biol Ther; 2007 Dec; 6(12):1997-2004. PubMed ID: 18087217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
    Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
    J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of endocan by Epstein-Barr virus latent membrane protein 1 and its clinical significance in nasopharyngeal carcinoma.
    Yu PH; Chou SF; Chen CL; Hung H; Lai CY; Yang PM; Jeng YM; Liaw SF; Kuo HH; Hsu HC; Chen JY; Wang WB
    PLoS One; 2013; 8(12):e82254. PubMed ID: 24340011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-encoded RNAs as a survival predictor in nasopharyngeal carcinoma.
    Ke K; Wang H; Fu S; Zhang Z; Duan L; Liu D; Ye J
    Chin Med J (Engl); 2014; 127(2):294-9. PubMed ID: 24438619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wild-type IDH2 contributes to Epstein-Barr virus-dependent metabolic alterations and tumorigenesis.
    Shi F; He Y; Li J; Tang M; Li Y; Xie L; Zhao L; Hu J; Luo X; Zhou M; Liu N; Fan J; Zhou J; Gao Q; Qiu S; Wu W; Zhang X; Jia W; Bode AM; Cao Y
    Mol Metab; 2020 Jun; 36():100966. PubMed ID: 32224436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Epstein-Barr virus and nasopharyngeal carcinoma in Caucasian patients.
    Plaza G; Manzanal AI; Fogué L; Santón A; Martínez-Montero JC; Bellas C
    Ann Otol Rhinol Laryngol; 2002 Mar; 111(3 Pt 1):210-6. PubMed ID: 11913680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance.
    Xie L; Shi F; Li Y; Li W; Yu X; Zhao L; Zhou M; Hu J; Luo X; Tang M; Fan J; Zhou J; Gao Q; Wu W; Zhang X; Liao W; Bode AM; Cao Y
    Signal Transduct Target Ther; 2020 May; 5(1):56. PubMed ID: 32433544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of Epstein-Barr virus and oncoprotein expression in nasopharyngeal carcinoma in Korea.
    Jeon YK; Lee BY; Kim JE; Lee SS; Kim CW
    Head Neck; 2004 Jul; 26(7):573-83. PubMed ID: 15229899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma.
    Chao TY; Chow KC; Chang JY; Wang CC; Tsao TY; Harn HJ; Chi KH
    Cancer; 1996 Jul; 78(1):24-9. PubMed ID: 8646721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma.
    Murono S; Yoshizaki T; Park CS; Furukawa M
    Histopathology; 1999 May; 34(5):432-8. PubMed ID: 10231418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy.
    Fang W; Zhang J; Hong S; Zhan J; Chen N; Qin T; Tang Y; Zhang Y; Kang S; Zhou T; Wu X; Liang W; Hu Z; Ma Y; Zhao Y; Tian Y; Yang Y; Xue C; Yan Y; Hou X; Huang P; Huang Y; Zhao H; Zhang L
    Oncotarget; 2014 Dec; 5(23):12189-202. PubMed ID: 25361008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy.
    Hu J; Li Y; Li H; Shi F; Xie L; Zhao L; Tang M; Luo X; Jia W; Fan J; Zhou J; Gao Q; Qiu S; Wu W; Zhang X; Liao W; Bode AM; Cao Y
    Theranostics; 2020; 10(26):11921-11937. PubMed ID: 33204320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Plasma Epstein-Barr Virus LMP1 and EBER1 with Circulating Tumor Cells and the Metastasis of Nasopharyngeal Carcinoma.
    Sun L; Wang Y; Shi J; Zhu W; Wang X
    Pathol Oncol Res; 2020 Jul; 26(3):1893-1901. PubMed ID: 31832991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells.
    Lo AK; Lo KW; Ko CW; Young LS; Dawson CW
    J Pathol; 2013 Jul; 230(3):336-46. PubMed ID: 23592276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBV-encoded RNA via TLR3 induces inflammation in nasopharyngeal carcinoma.
    Li Z; Duan Y; Cheng S; Chen Y; Hu Y; Zhang L; He J; Liao Q; Yang L; Sun LQ
    Oncotarget; 2015 Sep; 6(27):24291-303. PubMed ID: 26172457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma.
    Ruuskanen M; Leivo I; Minn H; Vahlberg T; Haglund C; Hagström J; Irjala H
    BMC Cancer; 2019 Jun; 19(1):624. PubMed ID: 31238894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma.
    Chen J; Hu CF; Hou JH; Shao Q; Yan LX; Zhu XF; Zeng YX; Shao JY
    J Transl Med; 2010 Mar; 8():30. PubMed ID: 20338061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.